2-Bromo-3-chloro-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one → 3-Chloro-2-(3-cyclopropylmethoxy-4-difluoromethoxyphenyl)-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one
Reaction equation
Br[C:2]1[N:11]([CH2:12][O:13][CH2:14][CH2:15][Si:16]([CH3:19])([CH3:18])[CH3:17])[C:5]2[CH:6]=[N:7][NH:8][C:9](=[O:10])[C:4]=2[C:3]=1[Cl:20].BrC1N(COCC[Si](C)(C)C)C2C=NNC(=O)C=2C=1.[CH:40]1([CH2:43][O:44][C:45]2[CH:46]=[C:47](B(O)O)[CH:48]=[CH:49][C:50]=2[O:51][CH:52]([F:54])[F:53])[CH2:42][CH2:41]1.C1(OC2C=C(B3OC(C)(C)C(C)(C)O3)C=CC=2OC(F)F)CC1>>[Cl:20][C:3]1[C:4]2[C:9](=[O:10])[NH:8][N:7]=[CH:6][C:5]=2[N:11]([CH2:12][O:13][CH2:14][CH2:15][Si:16]([CH3:19])([CH3:18])[CH3:17])[C:2]=1[C:47]1[CH:48]=[CH:49][C:50]([O:51][CH:52]([F:54])[F:53])=[C:45]([O:44][CH2:43][CH:40]2[CH2:42][CH2:41]2)[CH:46]=1Participants
5
Reactant 4
Product 1
Procedure
Reaction and post treatment were carried out in the same manner as in Example 1-(a) except for using 0.40 g (1.1 mmol) of 2-bromo-3-chloro-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one obtained in the following Reference example 16-(d) in place of 2-bromo-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo-[2,3-d]pyridazin-4-one, and using 0.55 g (2.1 mmol) of 3-cyclopropylmethoxy-4-difluoromethoxyphenylboronic acid obtained in the following Reference example 3-(b) in place of 2-(3-cyclopropoxy-4-difluoromethoxyphenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane, whereby 254 mg of the title compound was obtained as a white solid. (Yield: 46%)
Workup
- customReaction and post treatment
Sources & evidence
- ORD record
- ord-65300a002a5e41088d9bcca5cf6e9f7b
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450319B2
Reaction notes
Loading…